This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Medion Diagnostics Ag. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Iwan Aebischer: Innovator in Cell Population Analysis
Introduction
Iwan Aebischer is a notable inventor based in Fribourg, Switzerland. He has made significant contributions to the field of cellular analysis, particularly through his innovative patent that addresses the determination of minor cell populations in heterogeneous cell populations. His work is crucial for various medical applications, including the detection of low-concentration analytes on cells.
Latest Patents
Aebischer holds a patent titled "Method and device for the determination of minor cell population in heterogeneous cell populations." This invention involves a method for determining one or more cellularly bound analytes in a liquid sample. The device includes a feeding zone for applying the liquid sample, a porous membrane that allows cellular components to penetrate, and an indicator zone that interacts with the cellularly bound analyte. The method is designed to concentrate and quantify minor cell populations, which is essential in cases such as fetomaternal hemorrhage or chimeras.
Career Highlights
Throughout his career, Iwan Aebischer has worked with prominent companies in the diagnostics field. Notable among these are Medion Diagnostics AG and Grifols Diagnostic Solutions Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for cellular analysis.
Collaborations
Aebischer has collaborated with various professionals in his field, including his coworker Peter Schwind. These collaborations have further enhanced his research and development efforts in the area of cell population analysis.
Conclusion
Iwan Aebischer's contributions to the field of cellular analysis through his innovative patent demonstrate his commitment to advancing medical diagnostics. His work is vital for improving the detection and quantification of minor cell populations, which can have significant implications in healthcare.